P31 P31 Labs
๐Ÿ›ก๏ธ
๐ŸŸข LIVE

The Buffer

Fawn Guard Middleware for Stress Resilience

01. Architecture

The Buffer is standalone software that sits between the operator and Node One's hardware layer. It exists to keep interaction logic clear, auditable, and focused on communication support.

  • โ–ธ
    Zero AI in Firmware Hard constraint, not a limitation. No AI model is compiled into Node One's firmware. This is the primary compliance boundary โ€” continuous biometric signal processing by AI would trigger FDA Device classification.
  • โ–ธ
    Fawn Guard Logic Named after the trauma freeze/fawn response. Detects social compliance patterns โ€” the tendency to override authentic needs to maintain relational safety. Outputs a single, specific support prompt per trigger event. Never a stream.
  • โ–ธ
    Full Algorithmic Transparency Every recommendation has a visible, traceable rule path. The operator can read exactly why a suggestion was made. This is a compliance-by-design requirement, not a UX extra.
  • โ–ธ
    Single-Output Constraint One recommendation per decision point. Not a feed. Not a dashboard. One signal. This mirrors the 60gf switch philosophy โ€” friction is the feature.

02. Design Boundaries

The Buffer is pre-market communication support software. No FDA classification is claimed. Design boundaries keep interaction support transparent, operator-directed, and non-diagnostic.

BOUNDARY 1 โ€” OPERATOR CONTROL

The operator remains in control of all actions. Fawn Guard outputs are support prompts, not clinical directives.

BOUNDARY 2 โ€” NO BIOSIGNAL PIPELINE

The Buffer does not acquire or process continuous physiological biosignals. It responds to discrete operator-initiated events.

BOUNDARY 3 โ€” TRACEABLE LOGIC

The basis of every recommendation is always displayed to the operator. The rule that triggered the output is shown inline.

BOUNDARY 4 โ€” OVERRIDE ALWAYS AVAILABLE

The operator can override, dismiss, or independently verify any recommendation without consequence. The Buffer never locks, blocks, or escalates decisions.

Development Status

Phase
Architecture & regulatory mapping complete. Implementation in progress.
FDA Status
No classification claimed. Pre-market development (~85% complete).
Path to Market
513(g) Request for Information will be filed when ready for market. Binding FDA determination before any distribution.